Foto

Metlife Inc (MET) Given Average Rating of “Buy” by Brokerages

Tweet

Metlife Inc (NYSE:MET) has received a consensus recommendation of “Buy” from the fifteen analysts that are covering the firm, Marketbeat reports. Seven analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $52.90.

Several research firms recently weighed in on MET. Zacks Investment Research raised shares of Metlife from a “hold” rating to a “buy” rating and set a $50.00 price objective for the company in a research report on Tuesday, November 13th. Morgan Stanley upped their price objective on shares of Metlife from $52.00 to $54.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 13th. ValuEngine raised shares of Metlife from a “sell” rating to a “hold” rating in a research report on Wednesday, January 16th. Bank of America raised shares of Metlife from a “neutral” rating to a “buy” rating and set a $44.06 price objective for the company in a research report on Wednesday, January 16th. Finally, Argus reaffirmed a “buy” rating on shares of Metlife in a research report on Tuesday, February 12th. Get Metlife alerts:

MET stock opened at $44.16 on Monday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.14 and a current ratio of 0.14. Metlife has a 52 week low of $37.76 and a 52 week high of $48.92. The stock has a market capitalization of $43.58 billion, a P/E ratio of 8.19, a price-to-earnings-growth ratio of 0.97 and a beta of 1.20. Metlife (NYSE:MET) last released its quarterly earnings results on Wednesday, February 6th. The financial services provider reported $1.35 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.30 by $0.05. Metlife had a net margin of 7.53% and a return on equity of 10.24%. The business had revenue of $15.40 billion for the quarter, compared to the consensus estimate of $15.84 billion. During the same period in the prior year, the company posted $0.64 earnings per share. Metlife’s revenue was up .0% compared to the same quarter last year. On average, analysts predict that Metlife will post 5.48 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 13th. Stockholders of record on Tuesday, February 5th will be issued a $0.42 dividend. The ex-dividend date of this dividend is Monday, February 4th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 3.80%. Metlife’s dividend payout ratio (DPR) is currently 31.17%.

In other news, EVP Steven J. Goulart sold 10,292 shares of the stock in a transaction dated Tuesday, February 12th. The shares were sold at an average price of $44.40, for a total value of $456,964.80. Following the completion of the transaction, the executive vice president now owns 93,214 shares of the company’s stock, valued at $4,138,701.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink . Also, CFO John D. Mccallion sold 2,669 shares of the stock in a transaction dated Tuesday, February 12th. The stock was sold at an average price of $44.43, for a total transaction of $118,583.67. Following the completion of the transaction, the chief financial officer now directly owns 20,538 shares of the company’s stock, valued at approximately $912,503.34. The disclosure for this sale can be found here . 0.34% of the stock is currently owned by corporate insiders.

Several hedge funds have recently bought and sold shares of MET. Robeco Institutional Asset Management B.V. lifted its holdings in shares of Metlife by 21.0% in the third quarter. Robeco Institutional Asset Management B.V. now owns 1,114,103 shares of the financial services provider’s stock worth $52,050,000 after acquiring an additional 193,376 shares during the last quarter. Private Advisor Group LLC lifted its holdings in shares of Metlife by 43.3% in the third quarter. Private Advisor Group LLC now owns 39,455 shares of the financial services provider’s stock worth $1,843,000 after acquiring an additional 11,913 shares during the last quarter. Dupont Capital Management Corp raised its holdings in Metlife by 110.0% in the 3rd quarter. Dupont Capital Management Corp now owns 82,715 shares of the financial services provider’s stock valued at $3,864,000 after buying an additional 43,327 shares during the last quarter. Achmea Investment Management B.V. raised its holdings in Metlife by 13.8% in the 3rd quarter. Achmea Investment Management B.V. now owns 41,107 shares of the financial services provider’s stock valued at $1,919,000 after buying an additional 4,974 shares during the last quarter. Finally, Stone Ridge Asset Management LLC raised its holdings in Metlife by 12.5% in the 3rd quarter. Stone Ridge Asset Management LLC now owns 40,272 shares of the financial services provider’s stock valued at $1,882,000 after buying an additional 4,480 shares during the last quarter. 76.25% of the stock is owned by hedge funds and other institutional investors.

About Metlife

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. Metlife Metlife